{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:12:26Z","timestamp":1755216746167,"version":"3.43.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:p>Monumental progress has occurred in the diagnosis and treatment of childhood acute lymphoblastic leukemia dating back to the classic paper of Farber and colleagues in 1948. This historical review from the perspective of an individual, familiar with many of the waystations on this superhighway, will offer an admittedly personal review of the top 10 major contributions to the field. Fortunately, there have been many more additional advances beyond these 10 as we have witnessed an impressive improvement in overall survival from a few months 75 years ago to a cure rate of 85% in the world\u2019s more advanced countries. Other workers in the field assuredly would create a different list and ranking of these advances but the takeaway summation of the make-up and order of these lists is that advances have yielded improved and prolonged responses, a rational understanding of factors, both clinical and biological, that predict response and prognosis, the application of those factors to tailor therapy\u2019s intensity and duration to those factors and to discover and design modalities and targets of therapy that target our much more complete understanding of this most common malignancy of infants and children. On a very personal note, I vividly recall an early, ill-advised decision to devote my academic career to hematology\/oncology, with one glaring exception, acute lymphoblastic leukemia, and other malignancies. The stark realities of clinical practice and the harsh unmet needs and mostly unanswered challenges redirected my path that resulted in participation in many of these advances, making my own journey so gratifying and that of most of our patients so favorable.<\/jats:p>","DOI":"10.1097\/mph.0000000000002758","type":"journal-article","created":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T09:03:18Z","timestamp":1698397398000},"page":"429-435","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Top Ten Contributions of Pediatric Hematology\/Oncology to the Diagnosis and Treatment of Acute Lymphoblastic Leukemia"],"prefix":"10.1097","volume":"45","author":[{"given":"Denis R.","family":"Miller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,10,9]]},"reference":[{"key":"R1-20250804","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJM194806032382301","article-title":"Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid (aminopterin)","volume":"238","author":"Farber","year":"1948","journal-title":"N Engl J Med"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2141.2006.06119.x","article-title":"A tribute to Sidney Farber\u2014the father of modern chemotherapy","volume":"134","author":"Miller","year":"2006","journal-title":"Br J Haematol"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/rheumatology\/keac520","article-title":"Dr. Yellapragada SubbaRow\u2014the forgotten figure in the history of methotrexate","volume":"62","author":"Bagri","year":"2023","journal-title":"Rheumatology"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1182\/blood.V26.5.642.642","article-title":"The effectiveness of combinations of antileukemic agents in inducing and maintaining remission in children with acute leukemia","volume":"26","author":"Frei","year":"1965","journal-title":"Blood"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/s-2008-1026781","article-title":"Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83)","volume":"199","author":"Riehm","year":"1987","journal-title":"Klin Paediatr"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1053\/j.seminoncol.2008.07.008","article-title":"Progress in childhood cancer: 50 years of research collaboration: a report from the Children\u2019s Oncology Group","volume":"35","author":"O\u2019Leary","year":"2008","journal-title":"Semin Oncol"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/1097-0142(196909)24:3<427::AID-CNCR2820240302>3.0.CO;2-8","article-title":"The use of combination therapy in leukemia remission","volume":"24","author":"Leiken","year":"1969","journal-title":"Cancer"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1182\/blood.V37.3.272.272","article-title":"Central nervous system therapy and combination chemotherapy of childhood lymphocytic leukemia","volume":"37","author":"Aur","year":"1971","journal-title":"Blood"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1056\/NEJMra1400972","article-title":"Acute lymphoblastic leukemia in children","volume":"373","author":"Hunger","year":"2015","journal-title":"N Engl J Med"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199111073251902","article-title":"Second neoplasms after acute lymphoblastic leukemia in childhood","volume":"325","author":"Neglia","year":"1991","journal-title":"N Engl J Med"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/1097-0142(19830315)51:6<1041::AID-CNCR2820510612>3.0.CO;2-G","article-title":"Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG 141. A report from Children's Cancer Study Group","volume":"51","author":"Miller","year":"1983","journal-title":"Cancer"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/1097-0142(197409)34:3<508::AID-CNCR2820340306>3.0.CO;2-T","article-title":"Additive therapy in the maintenance of remission in acute lymphoblastic leukemia of childhood","volume":"14","author":"Miller","year":"1974","journal-title":"Cancer"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1200\/JCO.1989.7.12.1807","article-title":"Early response to induction therapy predicts early and late relapse in childhood acute lymphoblastic leukemia","volume":"7","author":"Miller","year":"1989","journal-title":"J Clin Oncol"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1182\/blood.V55.3.395.395","article-title":"Cell surface antigens: prognostic implications in childhood acute lymphocytic leukemia","volume":"55","author":"Sallan","year":"1980","journal-title":"Blood"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/mpo.2950180403","article-title":"Day 7 marrow response and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features","volume":"18","author":"Gaynon","year":"1990","journal-title":"Med Pediatr Oncol"},{"key":"R17-20250804","first-page":"1","article-title":"Minimal residual disease evaluation in childhood acute lymphoblastic leukemia: a clinical evidence review","volume":"16","author":"Schaink","year":"2016","journal-title":"Ont Health Technol Assess Ser"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1200\/JCO.1983.1.5.308","article-title":"Randomized study of 3 years versus 5 years of chemotherapy in childhood acute lymphoblastic leukemia","volume":"1","author":"Nesbit","year":"1983","journal-title":"J Clin Oncol"},{"key":"R19-20250804","first-page":"316","article-title":"Three versus five years of maintenance therapy are equivalent in childhood acute lymphoblastic leukemia: a report from the","volume":"7","author":"Miller","year":"1989","journal-title":"Childrens Cancer Study Group"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.3390\/jcm10173792","article-title":"Biologic and therapeutic implications of genomic alterations in acute lymphoblastic leukemia","volume":"10","author":"Iacobucci","year":"2021","journal-title":"J Clin Med"},{"key":"R21-20250804","first-page":"e042814","article-title":"Use of tyrosine kinase inhibitors for pediatric Ph chromosome-positive ALL: a systemic review and relationship","volume":"11","author":"Chen","year":"2021","journal-title":"Br Med J"},{"key":"R22-20250804","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1542\/peds.113.6.1833","article-title":"Section on hematology\/oncology. Policy statement on guidelines for pediatric cancer centers","volume":"113","year":"2004","journal-title":"Pediatrics"},{"key":"R23-20250804","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1182\/blood.V65.5.1079.1079","article-title":"Prognostic importance of blast call DNA content in childhood acute lymphoblastic leukemia","volume":"65","author":"Look","year":"1985","journal-title":"Blood"},{"key":"R24-20250804","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1182\/blood-2007-09-112920","article-title":"Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95","volume":"111","author":"M\u00f6ricke","year":"2008","journal-title":"Blood"},{"key":"R25-20250804","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1200\/JCO.1986.4.5.744","article-title":"Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the \u201cNew York\u201d regimen. A report from the Children's Cancer Study Group","volume":"4","author":"Steinherz","year":"1986","journal-title":"J Clin Oncol"},{"key":"R26-20250804","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/0140-6736(92)92103-M","article-title":"Bone marrow transplantation for high-risk childhood lymphoblastic leukaemia in first remission: experience in MRC UKALL X","volume":"340","author":"Chessells","year":"1992","journal-title":"Lancet"},{"key":"R27-20250804","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.3390\/jcm11082158","article-title":"Development of CAR-T cell therapy in children-a comprehensive review","volume":"11","author":"Boettcher","year":"2022","journal-title":"J Clin Med"},{"key":"R29-20250804","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1056\/NEJM197905033001807","article-title":"Cytogenetic evidence for the intrauterine origin of acute leukemia in monozygotic twins","volume":"300","author":"Chaganti","year":"1979","journal-title":"N Engl J Med"},{"key":"R30-20250804","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41568-018-0015-6","article-title":"A causal mechanism of childhood acute lymphoblastic leukaemia","volume":"18","author":"Greaves","year":"2018","journal-title":"Nat Rev Cancer"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002758","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:04:34Z","timestamp":1754337874000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,9]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002758","relation":{},"ISSN":["1077-4114"],"issn-type":[{"type":"print","value":"1077-4114"}],"subject":[],"published":{"date-parts":[[2023,10,9]]},"assertion":[{"value":"2023-06-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}